According to the company, it has received FDA approvals for the INTERCEPT Blood System
for platelets and plasma in 2014 and the system is now in routine use by a number of blood centres across the US, including the American Red Cross.
Under the three year agreement, the Karolinska University Hospital (KUH) will purchase the INTERCEPT Blood System
for platelets from Cerus.
16, the FDA also approved the Intercept Blood System
for the preparation of plasma to reduce the risk of transfusion-transmitted infections.
INTERCEPT and the INTERCEPT Blood System
are trademarks of Cerus Corporation.
According to the company, the INTERCEPT Blood System
for platelets is the first comprehensive blood safety measure for platelets and is designed to inactivate viruses, bacteria, parasites, and leukocytes (white blood cells) in platelet concentrates.
Biomedical products company Cerus Corporation (NasdaqGM:CERS) declared on Monday the launch of its purchase agreement for its INTERCEPT Blood System
for platelets and plasma with Shepeard Community Blood Center (Shepeard).
The approval of devices like the Intercept Blood System
allows blood establishments to prepare plasma that carries a lower risk of transmitting infectious pathogens through transfusion, said Karen Midthun, M.
benefiting from our many years of experience in Europe commercializing the INTERCEPT Blood System
and working with INTERCEPT plasma customers.
To date, the INTERCEPT Blood System
is the only technology approved in Switzerland for pathogen inactivation treatment of platelet and plasma components on a single platform.
Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements relating to the timing of the review process by the MCC, the potential approval and potential future launch of the INTERCEPT Blood System
for platelets in South Africa, and the potential benefits of the INTERCEPT Blood System
to safeguard patients from transfusion-transmitted infections.
With the adoption of the INTERCEPT Blood System
, we know we are doing everything in our power to provide patients with safe and effective blood products, consistent with our mission to use innovative products to continuously improve patient care," said Dr.
Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements relating to the number of platelets treated by the AKH using the INTERCEPT Blood System
, potential growth in the use of the INTERCEPT Blood System
the potential influence of the AKH over blood safety technology decisions in Austria and Europe.
Cerus Corporation (NASDAQ: CERS) announced today that Russia's Federal Medical-Biological Agency (FMBA) has awarded contracts for the purchase of 19 INTERCEPT Blood System
illumination devices for blood centers throughout the country.
In addition, the company is conducting clinical trials of the Intercept Blood Systems
in the United States: a Phase III trial for platelets, a Phase III trial for plasma and a Phase Ic trial for red blood cells.